Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids

Anticancer Research

Volumn 21, Issue 4 A, 2001, Pages 2273-2280

  Fu, L W ^a   Deng, Z A ^a   Pan, Q C ^a   Fan, W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bisbenzylisoquinoline alkaloids; Multidrug resistance; P glycoprotein; Structure activity relationship

Indexed keywords

ANTINEOPLASTIC ALKALOID; BISBENZYLISOQUINOLINE ALKALOID; DOXORUBICIN; FF 0011; FF 0012; FF 0014; FF 0015; FF 0018; FF 0019; GLYCOPROTEIN P; UNCLASSIFIED DRUG; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ALKALOIDS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOQUINOLINES; KB CELLS; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0035149284     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Biochemistry of multidrug resistance mediated by the multidrug transporter
2. Cell biological mechanisms of mutlidrug resistance in tumors
3. Multidrug resistance: Molecular mechanisms and clinical relevance
4. The P=glycoprotein efflux pump: How does it transport drugs?
5. Multidrug resistance in oncology: Diagnostic and therapeutic approaches
6. Reversal of multidrug resistance of tumor cells
7. Calcium antagonists as modulators of multi-drug resistant tumor cells
8. Functional modulation of multidrug resistance-related P-glycoprotein by Ca(2+)-calmodulin
9. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: Using recombinant cytosolic domains to establish structure-function relationships
10. Avoidance of doxorubicin resistance in osteosarcoma cells using a new quinoline derivative, MS-209
11. PSC833 cyclosporin A and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblasts
12. Overcoming of multidrug resistance by anti-P-glycoprotein monoclonal antibody
13. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells
14. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds
15. Biochemical and pharmacological characterization of MCF-7 drug-sensitive and AdrR multidrug-resistant human breast tumor xenografts in athymic nude mice
16. Vincristine-resistant human KB cell line and mechanism of multidrug resistance
17. Reversal of tumor multidrug resistance by 2-phenyl-3-(3′,5′-dimorpholinomethyl-4′hydroxy) -benzoyl-indole (HWL-12)
18. Antagonistic interplay between antimitotic and G1/S arresting agents observed in experimental combination therapy
19. In vitro evaluation of sequential-dependent combination between docetaxel and doxorubicin in human tumor cells
20. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO- 1078
21. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines
22. Discovery and charaterization of DC144-093, a novel inhibitor of Pglycoprotein-mediated multidrug resistance
23. Reversal of P-glycoprotein-mediated multidrug resistance by potent cyclopropyldibenzosuberane modultor, LY 335979
24. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA
25. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells
26. Structure-activity relationship of Verapamil analogs and reversal of multidrug resistance
27. Reversal of multidrug resistance by bis(phenylalkyl)amines and structurally related compounds
28. Multidrug resistance transporters and modulation